Bio Gene Technology Stock Fundamentals

BGT Stock   0.04  0  2.44%   
Bio Gene Technology fundamentals help investors to digest information that contributes to Bio Gene's financial success or failures. It also enables traders to predict the movement of Bio Stock. The fundamental analysis module provides a way to measure Bio Gene's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bio Gene stock.
At this time, Bio Gene's Depreciation And Amortization is comparatively stable compared to the past year. Interest Expense is likely to gain to about 63.8 K in 2024, whereas Other Operating Expenses is likely to drop slightly above 2.5 M in 2024.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Bio Gene Technology Company Shares Outstanding Analysis

Bio Gene's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Bio Gene Shares Outstanding

    
  201.36 M  
Most of Bio Gene's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bio Gene Technology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Bio Common Stock Shares Outstanding

Common Stock Shares Outstanding

141.82 Million

At this time, Bio Gene's Common Stock Shares Outstanding is comparatively stable compared to the past year.
Based on the latest financial disclosure, Bio Gene Technology has 201.36 M of shares currently outstending. This is 11.54% higher than that of the Chemicals sector and 88.44% higher than that of the Materials industry. The shares outstanding for all Australia stocks is 64.79% higher than that of the company.

Bio Gene Technology Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Bio Gene's current stock value. Our valuation model uses many indicators to compare Bio Gene value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bio Gene competition to find correlations between indicators driving Bio Gene's intrinsic value. More Info.
Bio Gene Technology is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bio Gene's earnings, one of the primary drivers of an investment's value.

Bio Shares Outstanding Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bio Gene's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bio Gene could also be used in its relative valuation, which is a method of valuing Bio Gene by comparing valuation metrics of similar companies.
Bio Gene is currently under evaluation in shares outstanding category among its peers.

Bio Fundamentals

About Bio Gene Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Bio Gene Technology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bio Gene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bio Gene Technology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Total Revenue18.3 K17.4 K
Cost Of Revenue319.8 K200.5 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Bio Stock Analysis

When running Bio Gene's price analysis, check to measure Bio Gene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Gene is operating at the current time. Most of Bio Gene's value examination focuses on studying past and present price action to predict the probability of Bio Gene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Gene's price. Additionally, you may evaluate how the addition of Bio Gene to your portfolios can decrease your overall portfolio volatility.